Capricor Therapeutics, Inc. · NASDAQ:CAPR
Sabar Karimah Es sold 115,000 Capricor Therapeutics, Inc. shares (Form 4)
Traded Mar 31 to Apr 1, 2026 · Filed Apr 1, 2026
From Mar 31 to Apr 1, 2026, Sabar Karimah Es (Director) sold 115,000 Capricor Therapeutics, Inc. shares at an average US$30.57 for US$3.52M under a trading plan, leaving 0 shares. Filed Apr 1, 2026 (Form 4).
- Sold
- 115,000 shares
- Price
- US$30.57 average (US$30.17 to US$31.03)
- Value
- US$3.52M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Option exercise | 61,265 | US$4.86 | 61,265 | Direct |
| Mar 31, 2026 | Common Stock | Sale | 61,265 | US$30.17 | 0 | Direct |
| Apr 1, 2026 | Common Stock | Option exercise | 53,735 | US$4.86 | 53,735 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 53,735 | US$31.03 | 0 | Direct |
Source
Related
- Capricor Therapeutics, Inc.
- Sabar Karimah Es
- Capricor Therapeutics, Inc. shareholders
- Form 4 · Sabar Karimah Es · Apr 3, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 14, 2026
- Schedule 13G · Millennium Management LLC · Sep 14, 2026
- Schedule 13G · Millennium Management LLC · Aug 19, 2026
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026